Related to:

News Massachusetts Board of Medicine Takes Disciplinary Action

Disciplinary action ordered at the February 22, 2018 meeting of the Board
  • Board of Registration in Medicine

WakefieldAt its meeting on February 22, 2018, the Massachusetts Board of Registration in Medicine took disciplinary action against the medical licenses of Arthur Pomerantz, M.D and Thomas R. Mayo, M.D.

In a Final Decision & Order, the Board revoked Dr. Arthur Pomerantz’s inchoate right to renew his medical license after finding that Dr. Pomerantz committed gross misconduct when he broke the sterile operation field during an operation on more than one occasion and engaged in numerous instances of disruptive behavior, including throwing surgical instruments. Dr. Pomerantz was licensed in Massachusetts from November 1981 until March 2015.  

The Board also suspended the license of Dr. Thomas R. Mayo after he agreed in a Consent Order that he had practiced medicine while his ability to do so was impaired. The indefinite suspension was stayed after a showing of eighteen months of sobriety and entry into a 5 year probation agreement.  Under the terms of the probation agreement, Dr. Mayo will not practice medicine until the Board approves a practice plan. Dr. Mayo was first licensed to practice medicine in May 2014.

The Massachusetts Board of Registration in Medicine licenses more than 40,000 physicians, osteopaths and acupuncturists.  The Board was created in 1894 to protect the public health and safety by setting standards for the practice of medicine and ensuring that doctors who practice in the Commonwealth are appropriately qualified and competent. The Board investigates complaints and determines sanctions. More information is available at, or you may contact the Board at



Massachusetts Board of Medicine Takes Disciplinary Action - February 22, 2018

Board of Registration in Medicine 

The Board of Registration in Medicine is responsible for licensing, regulation, and discipline of Massachusetts physicians and acupuncturists.


Tell us what you think